C
CG Oncology, Inc. (CGON)
NMS – Real Time Price. Currency in USD
71.96
-0.88 (-1.21%)
At close: Jun 26, 2026, 4:00 PM EDT
71.96
-0.00 (-0.00%)
After-hours: Jun 26, 2026, 4:34 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
71.96
-0.88 (-1.21%)
At close: Jun 26, 2026, 4:00 PM EDT
71.96
-0.00 (-0.00%)
After-hours: Jun 26, 2026, 4:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $33.7M significantly exceed its total debt $7.6M, ensuring strong financial flexibility
Total current assets $1.1B exceed Total current liabilities $35.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$57.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 31.30 | 6.05 | 10 | |
| Quick ratio | 31.25 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 191K | 204K | 1M | 4M | 5M |
| Gross Profit | 176K | 187K | 1M | -652K | -3M |
| Operating Income | -35M | -55M | -115M | -191M | -215M |
| Net Income | -35M | -49M | -88M | -161M | -187M |
| EBITDA | -35M | -55M | -115M | -189M | -213M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -22.57 | 1.0 |
| Next quarter | -22.72 | -22.19 | 1.0 |
| Current year | 173.55 | -31.9 | 5.5 |
| Next year | 689.4 | -3.42 | 5.5 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -53.35 | -45.73 | -29.08 | -58.03 | 1.0 |
| Y/Y | 1982.69 | -74.73 | -57.77 | -95.42 | 3.3 |
| 3y average | 239.95 | -67.02 | -36.41 | -64.59 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 2.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |